The Clinical Eye of the Year (Vuoden Kliininen Silmä) 2024The Clinical Eye (Kliininen silmä) -award was given to infectious diseases special Ulla Hohenthal and professor Jukka Hytönen for the…
!NEW PUBLICATION! – Clinical picture and outcome of the first identified case of human Neoehrlichia mikurensis infection in FinlandThe first identified case of human Neoehrlichia mikurensis infection in Finland Neoehrlichia mikurensis is a tick-borne bacterium that causes the…
TBD Turku Researchers Secure Research Counsil of Finland Funding for Lyme Disease StudiesTwo researchers from the University of Turku, Jani Sormunen and Jukka Hytönen, have been awarded significant funding from the Research…
NordTick2024 Conference RecapIn April 2024, TBD Turku participated in the fourth NordTick conference held at Nyborg Strand, Denmark, with six attendees: Jukka…
Clinical performance and analytical accuracy of a C6 peptide-based point-of-care lateral flow immunoassay in Lyme borreliosis serologyWe evaluated the analytical accuracy and the clinical performance of a ReaScan+ C6 LYME IgG point-of-care immunoassay (Reagena; index test)….
For the people by the people: Citizen science web interface for real-time monitoring of tick risk areas in FinlandTicks and tick-borne diseases (TBDs) form a significant and growing threat to human health and well-being in Europe, with increasing…
